Author: Ray Guarnieri

Moderna vs the NIH & the Spikevax Patent Battle! – Ep. 38 [Podcast]

Moderna vs the NIH & the Spikevax Patent Battle! – Ep. 38 [Podcast]

In this episode of Stuff You Should Know About IP, Thomas Colson and Raymond Guarnieri discuss a dispute regarding COVID-19 vaccine inventorship between the National Institute of Health (NIH) and Moderna. The NIH and the Biomedical Advanced Research and Development Authority (BARDA) invested in Moderna. Moderna has filed three patent applications, two of which relate directly to the mRNA-1273 sequence, and one of which is for a method of using the mRNA-1273 sequence. Moderna listed one or more inventors from the NIH on the patent application for the method of using the mRNA-1273 sequence, but did not list anyone from the NIH as an inventor on the other two patent applications.

The Battle of the Oats – Ep. 37[Podcast]

The Battle of the Oats – Ep. 37[Podcast]

Choosing the right brand of oat milk is becoming challenging with more and more companies entering into this multi-billion dollar industry. Cue the battle of the Oats, and this week’s episode of Stuff you Should Know About IP! Featuring special guest, Mark Caddle from Withers & Rogers, LLP.

The General Court finds meaning in MILEY CYRUS

The General Court finds meaning in MILEY CYRUS

Table of Contents This article was originally published by The Trademark Lawyer magazine To view the original article, follow the link below: https://trademarklawyermagazine.com/the-general-court-find-meaning-in-miley-cyrus/ By Tom Sharman, Partner and Rob McLaughlin, Assistant at Reddie & Grose LLP, a firm of patent and trademark

What is a Miley Cyrus? – Ep. 36 [Podcast]

What is a Miley Cyrus? – Ep. 36 [Podcast]

In this episode of Stuff You Should Know About IP, Thomas Colson and Raymond Guarnieri welcome special guest Rob McLaughlin to discuss a trademark case from the European Union that involves Miley Cyrus. Tom Colson loves Miley Cyrus. Miley Cyrus and her company, Smiley Miley, Inc., sought to register the trademark her name (“Miley Cyrus”), but another company that already had a trademark on “Cyrus” opposed Miley’s registration. There was some overlap in the products offered by the respective entities. Typically, trademark law concerns the question of whether consumers will be confused as to who makes or sells a particular product. In the EU, even when two trademarks look and sound very similar, if there is conceptual difference between them – i.e., if the two marks mean completely different things – then consumers will not be confused between the two marks, and the conceptual difference can override the other similarities between the marks. A trademark owner is usually able to prevent others from using the same trademark or a similar trademark on the exact same goods or similar goods in the country that granted the mark, however it is possible to register a trademark throughout the entire EU. A trademark registration can be opposed at the European Union Intellectual Property Office, or the EUPIO. Legal proceedings involving trademark issues can be time-consuming and expensive, especially if there are appeals. In this case, Miley Cyrus filed her registration in 2014, and the entire process took around seven years. Because Miley Cyrus is a famous individual, there is conceptual difference between her name, “Miley Cyrus,” and “Cyrus.” Unlike some celebrities who are sometimes known only by their last names, Miley Cyrus is not known simply as “Cyrus.” Initially, the Opposition Division at the EUIPO rejected Miley Cyrus’s application. Miley then appealed that decision to the Board of Appeal, but the Board upheld the Opposition Division’s decision. Miley Cyrus then appealed that decision with the General Court, and the General Court ruled in favor of Miley because she is famous and there is therefore conceptual difference between “Miley Cyrus” and “Cyrus” in the minds of consumers.

Artificial Intelligence = Inventor on a Patent? – Ep. 35 [Podcast]

Artificial Intelligence = Inventor on a Patent? – Ep. 35 [Podcast]

In this episode of Stuff You Should Know About IP, Thomas Colson and Raymond Guarnieri discuss naming an artificially intelligent system as an inventor on a patent application. Tom is terrified of, and slightly biased against, artificial intelligence, or “AI,” because AI is the greatest threat to humanity. Dr. Stephen Thaler, a physicist, filed two patent applications that named Device for Autonomous Bootstrapping of Unified Sentience, or “DABUS,” as inventor.

Oatly’s loss is victory for small producers

Oatly’s loss is victory for small producers

Oatly had claimed that the farm’s product, PureOaty, was too similar to its own, in both name and packaging design.

In its defence, Glebe Farm Foods argued that the brand name of its oat milk product and its packaging design featured generic terms and imagery, and there was no intention to mislead Oatly’s customers into believing the two rival brands were associated.

Trump Class Action Lawsuit: A Win for Copyrights – Ep. 34 [Podcast]

Trump Class Action Lawsuit: A Win for Copyrights – Ep. 34 [Podcast]

In this episode of Stuff You Should Know About IP, Thomas Colson and Raymond Guarnieri discuss issues that pertain to social media platforms and copyright infringement. Donald Trump and other plaintiffs filed class-action lawsuits against Facebook, YouTube, and Twitter. Under Section 230 of the Communications Decency Act of 1996, “No provider or user of an interactive computer service shall be treated as the publisher or speaker of any information provided by another information content provider.”

AIPPI releases position paper on TRIPS agreement COVID-19 waiver

AIPPI releases position paper on TRIPS agreement COVID-19 waiver

The Standing Committees on TRIPS and Pharma at the International Association for the Protection of Intellectual Property, (Association Internationale pour la Protection de la Propriété Intellectuelle – AIPPI), recently released an AIPPI Bureau approved position paper on the waiver for certain provisions of the TRIPS agreement for the prevention, containment and treatment of COVID-19 proposed by some countries within the WTO.

NFT Bragging Rights & IP Ownership – Ep. 33[Podcast]

NFT Bragging Rights & IP Ownership – Ep. 33[Podcast]

In this episode of Stuff You Should Know About IP, Thomas Colson and Raymond Guarnieri discuss non-fungible tokens, or NFTs. Jack Dorsey sold his first tweet as an NFT for more than $2.5 million. If an inventor invents an invention but does not want to patent it, the inventor can publish the invention so that nobody else can patent it. Electronic records can have digital fingerprints, which are random sets of numbers, letters, and characters; blockchain is like a more advanced version of that idea. Digital artists can struggle to make money because it is so easy for an audience to digitally copy their work. Through NFTs, digital artists can monetize their work because they can sell a one-of-a-kind original for a large sum of money.

Icons made by Freepik from www.flaticon.com